FTC’s challenge is the culmination of years of investigation, but choice of venue and theories of harm reveal potential weaknesses.

At the time, the insurer said it would save as much as $500 million a year by gaining more control over its drug purchasing.

Turns out there is room for more than one major professional team in town.

The announcements by Cigna, CVS, Humana, Centene, and UnitedHealth were made ahead of the beginning of Medicare Advantage enrollment, which begins Oct. 15. Among other news, a top California health ...

UnitedHealthcare today introduced its 2025 Medicare Advantage plans, featuring more choice, broad access to care and stability in the most popular benefits to meet the evolving and varied needs of ...

Federal officials resolved more than a decade ago to crack down on whopping government overpayments to private Medicare ...

Health insurance companies including CVS Health's Aetna, Cigna and Humana are pulling back slightly on their Medicare Advantage footprints after years of expansions.

Blue Shield of California is set to offer Humira, one of the world’s top-selling drugs, to patients for free in a bid to show ...

Pfizer withdrew its sickle cell disease treatment Oxbryta. Meanwhile, Senators introduce new bill to fortify health-care ...

In this article, we will look at where UnitedHealth Group Incorporated (UNH) ranks among the best stocks to invest in for the medium term. On September 18, the Federal Reserve reduced its policy rate ...

Blue Shield of California struck an unusual deal to buy a lower-cost version of Humira directly from a manufacturer, ...

New court filings and lobbying reports reveal an industry drive to tamp down critics — and retain billions of dollars in ...